MSTP Curriculum
MSTP Curriculum
The MS Translational Pharmacology curriculum consists of 30-36 credits organized into three curricular areas:
- Clinical and translational pharmacology and toxicology coursework.
- Conduct of clinical trials or preclinical studies coursework, including courses in biostatistics.
- Culminating project: development of clinical trial or preclinical study protocol and manuscript.
As a final master’s degree assessment, all students must pass a comprehensive exam in their final semester. The MS Translational Pharmacology program does not require a thesis.
Two tracks are offered to specialize your training:
- Clinical Pharmacology and Clinical Trial Design
- Toxicology and Safety Pharmacology
(Please note the online MS Translational Pharmacology degree is not a lab-based program.)
100% ONLINE:
The MS Translational Pharmacology program is offered 100% online in an asynchronous format by The Ohio State University College of Medicine, Dept. of Biological Chemistry and Pharmacology in collaboration with the OSU Colleges of Pharmacy and Nursing.
1 Who Should Apply?
The MS Translational Pharmacology program is appropriate for healthcare practitioners as well as those having completed a B.S. or graduate degree in the pharmaceutical sciences or other bioscience-related field.
2 Prerequisites
Applicants not holding a bachelor’s degree or higher in a clinical, health science or bioscience field must have completed coursework in biology and chemistry; introductory courses in biochemistry and physiology are recommended but not required. Students who have not previously completed coursework in general pharmacology (graduate level) and pathophysiology (any level) will be required to complete these courses in the program.
3 Career Opportunities
Graduates with this master’s degree may find rewarding clinical research career opportunities as clinical trials administers, project managers, quality assurance specialists, and in pharmaceutical sales. In organizations conducting preclinical drug studies, graduates may find entry- and mid-level opportunities as study coordinators and directors, quality assurance specialists, laboratory animal resource managers, and project/program managers. Graduates already holding a doctorate degree may leverage this master’s degree to advance their careers as clinical investigators, research scientists, clinical pharmacologists, or medical affairs specialists in the pharmaceutical industry, contract research organizations, clinical research organizations, and academic medical centers.
4 Programs of Study
The MS Translational Pharmacology curriculum consists of 30-36 credits organized into three curricular areas:
- Clinical and translational pharmacology and toxicology coursework
- Conduct of clinical trials or preclinical studies coursework, including courses in biostatistics
- Culminating project: development of clinical trial or preclinical study protocol and manuscript
As a final master’s degree assessment, all students must pass a final master’s comprehensive exam in their final semester. The MS Translational Pharmacology program does not require a thesis.
Coursework Requirements:
Core Courses (9-15 Credits Required) |
|
|
|
Specialization Courses (Additional 18 Credits Required) |
|
Clinical Pharmacology and Clinical Trial Design |
Toxicology and Safety Pharmacology |
|
Toxicology Courses:
Safety Pharmacology Courses:
The following course may be substituted for a toxicology or safety pharmacology course above (3-6), with advisor permission:
|
Culminating Project (3 Credits Required) |
|
| BIOPRHM 7598: Scientific Writing: Clinical Trial Protocol and Manuscript Development |
Pharmacy 7597: Scientific Writing: Preclinical Study Protocol and Manuscript Development |
*General pharmacology may be waived for clinicians (MD, DO, PharmD, NP, PA, etc.) and other students who have completed a graduate-level general pharmacology course (grade B or better).
**Pathophysiology may be waived for clinicians and other students who have completed any college-level pathophysiology course (graduate or undergraduate, grade B or better).Department abbreviations:
- BIOPHRM = Biological Chemistry and Pharmacology
- CBG = Cancer Biology and Genetics
- HTHRHSC = Health and Rehabilitation Sciences
- PUBHBIO = Public Health Biostatistics
Course Descriptions:
BIOETHC 60103 credits |
Biomedical Research EthicsThe broad intent of this course is to highlight the importance of ethics in biomedical research and to explore how critical ethical thinking can be used to analyze personal decision-making, public regulation, and the law concerning advanced biomedical sciences/technologies and their clinical applications.
|
BIOPHRM 56003 credits |
Introduction to General PharmacologyIntroductory course emphasizing the general principles of pharmacology using a systems-based and mechanism-based approach. The course provides a simple overview of the subject.
|
HTHRHSC 55004 credits |
Introduction to PathophysiologyFundamental concepts of pathophysiology including etiology, signs, symptoms, diagnosis, treatment, and complications of major body system disorders.
|
Pharmacy 50053 credits |
Fundamentals of PathophysiologyThis course provides a fundamental overview of human pathophysiology by comparing dysfunctional body processes to normal physiological function. Case studies will be applied to pathophysiological phenomena.
|
Pharmacy 75503 credits |
Research Applications of Clinical PharmacologyApplication of basic and advanced conceptsin pharmacology to contemporary research literature to solidify understanding of the pharmacologic principles underlying the individualization of drug therapy and contemporary drug development. Fundamentals of clinical pharmacology for the development, evaluation, and clinical use of pharmaceutical products. Requirement in Clinical Pharmacology specialization.
|
Pharmacy 75603 credits |
Clinical Trials I: Design and RegulationThis course provides a fundamental overview of clinical trial design, methods, and regulationwith an emphasis on medicalproduct development, clinicaltrial protocols, preclinical research requirements, and the appraisal of published clinical trials.
|
Pharmacy 75613 credits |
Clinical Trials II: Site Management and Study LeadershipThis course provides a fundamental overviewof best practices of clinicaltrial study and site management, including an emphasis on data, safety, and quality management, and study team leadership.
|
Pharmacy 75623 credits |
Design and Management of Preclinical StudiesProvides a fundamental overview of preclinical study design, methods, and regulation with an introduction to the clinical development process. Provides a synopsis of best practices of preclinical trialsite and study management, qualityand data management, and leadership in the context of preclinical and translational research endeavors.
|
Pharmacy 75803 credits |
Principles of SafetyPharmacologyIntroduction to organ system studies of current experimental models, risk assessment, and regulatory guidelines for evaluating drug candidates in various organ systems.
|
Pharmacy 75823 credits |
Organ System ToxicologyPrinciples of toxicology, physiology, and pharmacology as they relate to adverse and unanticipated drug effects. Emphasison cardiovascular, nervous, pulmonary, liver, and kidney systems.
|
Pharmacy 75833 credits |
Advanced Organ Systems Toxicology and Risk AssessmentPrinciples of risk assessment, toxicology, and physiology as they relate to effects of chemical and pharmacologic agents on the blood, immune, ocular, skin, reproductive, endocrine systems. Includes a review of chemical carcinogenesis, genetic, and developmental toxicity as they relate to chemical or drug exposure.
|
Pharmacy 75843 credits |
Applied Pharmacokinetics and PharmacodynamicsIntroduction to basic and advanced concepts in pharmacokinetics, pharmacodynamics, and pharmacology for clinical investigators and other research professionals participating in the conduct of clinical trials.
|
Pharmacy 75863 credits |
Integrative in Vivo Modeling for Drug Development: Application for Safety and Clinical PharmacologyEvaluating drug effects and animal models for safety and toxicity assessment.
|
Pharmacy 75883 credits |
Toxic SubstancesSurvey the effects of toxic substances on biological systems including the mechanism of action for major toxicants, sources of toxicants, signs and symptoms associated with intoxications, and methods of treatment. Substances presented will include those that may be encountered occupationally, environmentally, medically, and in the context of substance abuse.
|
Pharmacy 75953 credits |
Scientific Writing:
|
Pharmacy 75973 credits |
Scientific Writing:
|
Pharmacy 77843 credits |
Data Analysis and Interpretation in Clinical and Preclinical ResearchIntroduction to the principles of biostatistical methods used in biomedical research. Analysis of clinical and preclinical research data and interpretation of statistical results in biomedical studies.
|
PUBHBIO 62103 credits Online AND In-person |
Applied Biostatistics ITheory and application of basic statistical concepts for design of studies in health sciences, integrated with statistical software applications.
|
PUBHBIO 62113 credits Online AND In-person |
Applied Biostatistics IIA second course in applied biostatistical methods with an emphasis on regression methods commonly used in the health sciences. The focus is on linearregression and ANOVA. Integrated with use of computer statistical packages.
|
BIOPHRM/CBG/
|
Introduction to Personalized Therapeutics and PharmacogenomicsExploration of the trend to therapy tailored to the individual patient rather than “one drug fits all;” inter-individual differences in drug responses, with emphasis on genetic and genomic factors; ethical, regulatory, and economic issues that impact drug therapies.
|